ATE378342T1 - Terminal verzweigte, polymere linker und diese enthaltende polymere konjugate - Google Patents
Terminal verzweigte, polymere linker und diese enthaltende polymere konjugateInfo
- Publication number
- ATE378342T1 ATE378342T1 AT02721033T AT02721033T ATE378342T1 AT E378342 T1 ATE378342 T1 AT E378342T1 AT 02721033 T AT02721033 T AT 02721033T AT 02721033 T AT02721033 T AT 02721033T AT E378342 T1 ATE378342 T1 AT E378342T1
- Authority
- AT
- Austria
- Prior art keywords
- polymeric
- containing same
- linkers
- conjugates containing
- terminally branched
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/329—Polymers modified by chemical after-treatment with organic compounds
- C08G65/333—Polymers modified by chemical after-treatment with organic compounds containing nitrogen
- C08G65/33396—Polymers modified by chemical after-treatment with organic compounds containing nitrogen having oxygen in addition to nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/329—Polymers modified by chemical after-treatment with organic compounds
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L2203/00—Applications
- C08L2203/02—Applications for biomedical use
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Polymers & Plastics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
- Polyethers (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Graft Or Block Polymers (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US27000901P | 2001-02-20 | 2001-02-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE378342T1 true ATE378342T1 (de) | 2007-11-15 |
Family
ID=23029515
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02721033T ATE378342T1 (de) | 2001-02-20 | 2002-02-19 | Terminal verzweigte, polymere linker und diese enthaltende polymere konjugate |
Country Status (10)
Country | Link |
---|---|
US (1) | US20020183259A1 (de) |
EP (1) | EP1362053B1 (de) |
JP (1) | JP2004532289A (de) |
AT (1) | ATE378342T1 (de) |
AU (1) | AU2002251988A1 (de) |
CA (1) | CA2437989A1 (de) |
DE (1) | DE60223499T2 (de) |
DK (1) | DK1362053T3 (de) |
MX (1) | MXPA03007392A (de) |
WO (1) | WO2002065988A2 (de) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6624142B2 (en) * | 1997-12-30 | 2003-09-23 | Enzon, Inc. | Trimethyl lock based tetrapartate prodrugs |
JP4814488B2 (ja) | 2001-10-18 | 2011-11-16 | ネクター セラピューティックス | 重合体共役物オピオイドアンタゴニスト |
US7332164B2 (en) * | 2003-03-21 | 2008-02-19 | Enzon Pharmaceuticals, Inc. | Heterobifunctional polymeric bioconjugates |
AU2004230927B9 (en) | 2003-04-13 | 2011-12-01 | Enzon Pharmaceuticals, Inc. | Polymeric oligonucleotide prodrugs |
AU2004238870B8 (en) | 2003-05-12 | 2010-04-15 | Affymax, Inc. | Novel peptides that bind to the erythropoietin receptor |
MXPA05012314A (es) | 2003-05-12 | 2006-04-18 | Affymax Inc | Radical separador para peptido modificado con polietilenglicol. |
SI1625156T1 (sl) | 2003-05-12 | 2013-02-28 | Affymax, Inc. | Peptidi, ki se veĹľejo k eritropoetinskemu receptorju |
MXPA05012315A (es) * | 2003-05-12 | 2006-04-18 | Affymax Inc | Compuestos poli(etilenglicol) modificados novedosos y usos de los mismos. |
US20060182692A1 (en) | 2003-12-16 | 2006-08-17 | Fishburn C S | Chemically modified small molecules |
NZ548529A (en) | 2003-12-16 | 2010-08-27 | Nektar Therapeutics | Pegylated small molecules |
KR101203475B1 (ko) * | 2004-09-22 | 2012-11-21 | 니폰 가야꾸 가부시끼가이샤 | 신규 블록 공중합체, 미셀 제제물 및 이를 유효성분으로함유하는 항암제 |
JP5000512B2 (ja) * | 2005-05-11 | 2012-08-15 | 日本化薬株式会社 | シチジン系代謝拮抗剤の高分子誘導体 |
US7550433B2 (en) | 2005-06-03 | 2009-06-23 | Affymax, Inc. | Erythropoietin receptor peptide formulations and uses |
PL2279758T3 (pl) | 2005-06-16 | 2015-07-31 | Nektar Therapeutics | Koniugaty mające degradowalne połączenie oraz odczynniki polimerowe użyteczne w wytwarzaniu takich koniugatów |
US8323669B2 (en) | 2006-03-28 | 2012-12-04 | Nippon Kayaku Kabushiki Kaisha | Polymer conjugate of taxane |
JP5181347B2 (ja) | 2006-05-18 | 2013-04-10 | 日本化薬株式会社 | ポドフィロトキシン類の高分子結合体 |
WO2008010463A1 (fr) * | 2006-07-19 | 2008-01-24 | Nippon Kayaku Kabushiki Kaisha | Conjugué polymère d'une combrétastatine |
EP2073820A4 (de) * | 2006-09-15 | 2014-07-16 | Belrose Pharma Inc | Gezielte polymer-prodrugs mit multifunktionalen verknüpfern |
JP5548364B2 (ja) * | 2006-10-03 | 2014-07-16 | 日本化薬株式会社 | レゾルシノール誘導体の高分子結合体 |
WO2008056596A1 (en) | 2006-11-06 | 2008-05-15 | Nippon Kayaku Kabushiki Kaisha | Polymeric derivative of nucleic acid metabolic antagonist |
WO2008056654A1 (en) | 2006-11-08 | 2008-05-15 | Nippon Kayaku Kabushiki Kaisha | Polymeric derivative of nucleic acid metabolic antagonist |
EP2118127A4 (de) | 2007-01-31 | 2010-12-01 | Affymax Inc | Linker auf stickstoffbasis zur bindung modifizierender gruppen an polypeptide und andere makromoleküle |
EP2206502B1 (de) | 2007-09-28 | 2018-09-12 | Nippon Kayaku Kabushiki Kaisha | Polymer-konjugat eines steroids |
CN101977631A (zh) * | 2008-03-18 | 2011-02-16 | 日本化药株式会社 | 生理活性物质的高分子量偶联物 |
EP2284209B1 (de) | 2008-05-08 | 2016-08-31 | Nippon Kayaku Kabushiki Kaisha | Polymerkonjugat aus folsäure oder einem folsäurederivat |
US8808749B2 (en) | 2009-05-15 | 2014-08-19 | Nippon Kayaku Kabushiki Kaisha | Polymer conjugate of bioactive substance having hydroxy group |
NZ609874A (en) | 2010-09-30 | 2014-10-31 | Astrazeneca Ab | Crystalline naloxol-peg conjugate |
WO2012067138A1 (ja) | 2010-11-17 | 2012-05-24 | 日本化薬株式会社 | 新規なシチジン系代謝拮抗剤の高分子誘導体 |
WO2013024048A1 (en) * | 2011-08-12 | 2013-02-21 | Ascendis Pharma A/S | Polymeric hyperbranched carrier-linked prodrugs |
JP5711378B2 (ja) | 2011-09-11 | 2015-04-30 | 日本化薬株式会社 | ブロック共重合体の製造方法 |
EP3820879A4 (de) | 2018-06-29 | 2022-04-13 | Shanghai Changchengyiyaokeji Company Limited | Phosphorhaltige prodrugs von gemcitabin |
Family Cites Families (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4179337A (en) * | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
IL83966A (en) * | 1986-09-26 | 1992-03-29 | Schering Ag | Amides of aminopolycarboxylic acids and pharmaceutical compositions containing them |
US4943579A (en) * | 1987-10-06 | 1990-07-24 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Water soluble prodrugs of camptothecin |
JP2958019B2 (ja) * | 1988-05-06 | 1999-10-06 | 住友製薬株式会社 | ポリエチレングリコール誘導体、修飾ペプチドおよびその製造方法 |
US5112739A (en) * | 1988-08-02 | 1992-05-12 | Polaroid Corporation | Enzyme controlled release system |
US5283339A (en) * | 1988-11-23 | 1994-02-01 | California Institute Of Technology | Immobilized metal aqueous two-phase extraction and precipitation |
US5122614A (en) * | 1989-04-19 | 1992-06-16 | Enzon, Inc. | Active carbonates of polyalkylene oxides for modification of polypeptides |
US6039931A (en) * | 1989-06-30 | 2000-03-21 | Schering Aktiengesellschaft | Derivatized DTPA complexes, pharmaceutical agents containing these compounds, their use, and processes for their production |
CA2072360A1 (en) * | 1989-12-26 | 1991-06-27 | Abraham J. Domb | Prodrug anhydride compositions |
US5552391A (en) * | 1990-01-16 | 1996-09-03 | La Jolla Pharmaceutical Company | Chemically-defined non-polymeric valency platform molecules and conjugates thereof |
US5130126A (en) * | 1990-07-09 | 1992-07-14 | Nippon Oil & Fats Co., Ltd. | Polymer-drug conjugate and a method of producing it |
JP3051145B2 (ja) * | 1990-08-28 | 2000-06-12 | 住友製薬株式会社 | 新規なポリエチレングリコール誘導体修飾ペプチド |
FR2676058B1 (fr) * | 1991-04-30 | 1994-02-25 | Hoechst Lab | Prodrogues glycosylees, leur procede de preparation et leur utilisation dans le traitement des cancers. |
US5433886A (en) * | 1992-05-07 | 1995-07-18 | Calgon Corporation | Stabilization of polyether polyamino methylene phosphonate scale inhibitors against degradation by bromine and chlorine biocides |
AU4406793A (en) * | 1992-06-04 | 1993-12-30 | Clover Consolidated, Limited | Water-soluble polymeric carriers for drug delivery |
GB9213077D0 (en) * | 1992-06-19 | 1992-08-05 | Erba Carlo Spa | Polymerbound taxol derivatives |
US5614549A (en) * | 1992-08-21 | 1997-03-25 | Enzon, Inc. | High molecular weight polymer-based prodrugs |
US5382657A (en) * | 1992-08-26 | 1995-01-17 | Hoffmann-La Roche Inc. | Peg-interferon conjugates |
US5756825A (en) * | 1992-09-08 | 1998-05-26 | Safavy; Ahmad | Hydroxamic acid-based bifunctional chelating compounds |
KR950703582A (ko) * | 1992-10-14 | 1995-09-20 | 조이스 이. 마임스 | 킬레이트화 중합체(chelating polymers) |
US5349001A (en) * | 1993-01-19 | 1994-09-20 | Enzon, Inc. | Cyclic imide thione activated polyalkylene oxides |
US5321095A (en) * | 1993-02-02 | 1994-06-14 | Enzon, Inc. | Azlactone activated polyalkylene oxides |
US5547981A (en) * | 1993-03-09 | 1996-08-20 | Enzon, Inc. | Taxol-7-carbazates |
US5454954A (en) * | 1993-09-21 | 1995-10-03 | Calgon Corporation | Scale control in metal mining circuits using polyether polyamino methylene phosphonates |
US5965566A (en) * | 1993-10-20 | 1999-10-12 | Enzon, Inc. | High molecular weight polymer-based prodrugs |
CA2174350A1 (en) * | 1993-10-20 | 1995-04-27 | Richard B. Greenwald | 2'- and/or 7- substituted taxoids |
US5840900A (en) * | 1993-10-20 | 1998-11-24 | Enzon, Inc. | High molecular weight polymer-based prodrugs |
US5880131A (en) * | 1993-10-20 | 1999-03-09 | Enzon, Inc. | High molecular weight polymer-based prodrugs |
US5643575A (en) * | 1993-10-27 | 1997-07-01 | Enzon, Inc. | Non-antigenic branched polymer conjugates |
US5919455A (en) * | 1993-10-27 | 1999-07-06 | Enzon, Inc. | Non-antigenic branched polymer conjugates |
US5605976A (en) * | 1995-05-15 | 1997-02-25 | Enzon, Inc. | Method of preparing polyalkylene oxide carboxylic acids |
US5646159A (en) * | 1994-07-20 | 1997-07-08 | Research Triangle Institute | Water-soluble esters of camptothecin compounds |
US5672335A (en) * | 1994-11-30 | 1997-09-30 | Schering Aktiengesellschaft | Use of metal complexes as liver and gallbladder X-ray diagnostic agents |
US5489589A (en) * | 1994-12-07 | 1996-02-06 | Bristol-Myers Squibb Company | Amino acid derivatives of paclitaxel |
GB9501052D0 (en) * | 1995-01-19 | 1995-03-08 | Cancer Res Campaign Tech | Improvements relating to prodrugs |
US5672584A (en) * | 1995-04-25 | 1997-09-30 | The University Of Kansas | Cyclic prodrugs of peptides and peptide nucleic acids having improved metabolic stability and cell membrane permeability |
US5679852A (en) * | 1995-06-02 | 1997-10-21 | Schering Aktiengesellschaft | Process for the production of DTPA-monoamides of the central carboxylic acid and their use as pharmaceutical agents |
EP0751144B1 (de) * | 1995-06-27 | 2004-10-06 | Pharmachemie B.V. | Anthracyclin Prodrugs, Verfahren zu deren Herstellung und deren Verwendung in der selektiven Chemotherapie |
US6020373A (en) * | 1995-10-20 | 2000-02-01 | Eastern Virginia Medical School | Chelate derivatives as protectors against tissue injury |
WO1997020563A1 (en) * | 1995-11-22 | 1997-06-12 | The Johns-Hopkins University | Ligands to enhance cellular uptake of biomolecules |
US6011042A (en) * | 1997-10-10 | 2000-01-04 | Enzon, Inc. | Acyl polymeric derivatives of aromatic hydroxyl-containing compounds |
US6135655A (en) * | 1997-10-14 | 2000-10-24 | Hewlett-Packard Company | Multipixel dots in monochrome drop-on-demand printing |
US5965119A (en) * | 1997-12-30 | 1999-10-12 | Enzon, Inc. | Trialkyl-lock-facilitated polymeric prodrugs of amino-containing bioactive agents |
US6153655A (en) * | 1998-04-17 | 2000-11-28 | Enzon, Inc. | Terminally-branched polymeric linkers and polymeric conjugates containing the same |
-
2002
- 2002-02-19 AT AT02721033T patent/ATE378342T1/de not_active IP Right Cessation
- 2002-02-19 DK DK02721033T patent/DK1362053T3/da active
- 2002-02-19 WO PCT/US2002/004781 patent/WO2002065988A2/en active IP Right Grant
- 2002-02-19 JP JP2002565549A patent/JP2004532289A/ja active Pending
- 2002-02-19 CA CA002437989A patent/CA2437989A1/en not_active Abandoned
- 2002-02-19 EP EP02721033A patent/EP1362053B1/de not_active Expired - Lifetime
- 2002-02-19 US US10/078,730 patent/US20020183259A1/en not_active Abandoned
- 2002-02-19 MX MXPA03007392A patent/MXPA03007392A/es unknown
- 2002-02-19 AU AU2002251988A patent/AU2002251988A1/en not_active Abandoned
- 2002-02-19 DE DE60223499T patent/DE60223499T2/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP1362053A2 (de) | 2003-11-19 |
WO2002065988A2 (en) | 2002-08-29 |
EP1362053A4 (de) | 2005-01-19 |
MXPA03007392A (es) | 2003-12-04 |
CA2437989A1 (en) | 2002-08-29 |
WO2002065988A3 (en) | 2003-04-10 |
DK1362053T3 (da) | 2008-03-10 |
EP1362053B1 (de) | 2007-11-14 |
AU2002251988A1 (en) | 2002-09-04 |
JP2004532289A (ja) | 2004-10-21 |
DE60223499T2 (de) | 2008-10-16 |
DE60223499D1 (de) | 2007-12-27 |
US20020183259A1 (en) | 2002-12-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE378342T1 (de) | Terminal verzweigte, polymere linker und diese enthaltende polymere konjugate | |
ATE378071T1 (de) | Endgruppenverzweigte polymere verbindungen und diese enthaltende polymere konjugate | |
CY1121314T1 (el) | Παραγωγο ραπαμυκινης για την θεραπευτικη αντιμετωπιση του καρκινου του πνευμονα | |
NO20013451L (no) | 1-Heterocyklus-substituerte diarylaminer | |
EP1181323A4 (de) | Biomaterialien die durch nukleophile reaktion auf konjugierten ungesättigten gruppen addiert sind | |
AU7522601A (en) | Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds | |
DK1093819T3 (da) | Forbindelse og præparat til tilförsel af aktive midler | |
WO2007076371A3 (en) | Hydrophobic core carrier compositions for delivery of therapeutic agents, methods of making and using the same | |
DE60239707D1 (de) | Antimikrobielle kationische peptide und diese enthaltende formulierungen | |
DK1200412T3 (da) | Antiproliferative imidazolforbindelser | |
TR200101103T2 (tr) | CGMP PDE-İnhibitörü içeren kontrollu serbest bırakılan farmasötik formülasyonlar | |
IL166561A0 (en) | Pharmaceutical compositions | |
MXPA02012817A (es) | Drogas antineoplasicas liposomales y uso de las mismas. | |
CY1106366T1 (el) | Ενωση λακταμης για την αναστολη της απελευθερωσης ή της συνθεσης βητα-αμυλοειδους πεπτιδιου | |
CY1105538T1 (el) | Ιατρικη μορφοποιηση αερολυματος | |
HK1065714A1 (en) | Compositions for delivery of drug combinations | |
DE10084671T1 (de) | Pharmazeutische Zusammensetzungen | |
TR199901104T2 (xx) | Farmas�tik bile�ikler. | |
IL157540A0 (en) | N-(aryl)-2-arylethenesulphonamides and therapeutic uses thereof | |
DE69907926D1 (de) | 1,2,4-triazol-3-thion verbindungen | |
WO2000053231A3 (en) | Fatty acid-anticancer conjugates and uses thereof | |
HUP0100350A2 (hu) | A prosztatarák kezelésére alkalmazható konjugátumok, azokat hatóanyagként tartalmazó gyógyászati készítmények, elárás ezek előállítására, valamint alkalmazásuk | |
DK1666924T3 (da) | Kovalent bundne, hydrofile belægningssammensætninger til implantater | |
NO20014803L (no) | Pyrido-tieno-diazepiner, fremgangsmåte for fremstilling derav og farmasöytiske blandinger inneholdende dem | |
DK1142905T3 (da) | Hidtil ukendt depsipeptidforbindelse |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |